Taxoid compounds in breast cancer: current status and future prospects.
作者： Martine J. Piccart
DOI: 10.1007/978-1-4615-2007-8_9
关键词:
摘要: Breast cancer, once it has recurred at distant sites, is a lethal disease, the natural history of which changed very little over past 20 years. After failure hormonal manipulation, outlook for these patients remains dismal, in spite wide use combination chemotherapy and introduction anthracyclines, currently considered to be most active drugs this disease.
springer.com
ulb.ac.be
core.ac.uk 
sci-hub.st 参考文章(34)
RT Chlebowski, RV Smalley, JM Weiner, LE Irwin, AA Bartolucci, JR Bateman, Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group. British Journal of Cancer. ,vol. 59, pp. 227- 230 ,(1989) , 10.1038/BJC.1989.46
A. Setanoians, P. Wilson, M. A. Graham, V. Auzannet, G. A. Chadwick, D. J. Kerr, N. Le Bail, S. B. Kaye, D. Bissett, J. Cassidy, Phase I and Pharmacokinetic Study of Taxotere (RP 56976) Administered as a 24-Hour Infusion Cancer Research. ,vol. 53, pp. 523- 527 ,(1993)
E K Rowinsky, M R Gilbert, W P McGuire, D A Noe, L B Grochow, A A Forastiere, D S Ettinger, B G Lubejko, B Clark, S E Sartorius, Sequences of Taxol and Cisplatin: A Phase I and Pharmacologic Study Journal of Clinical Oncology. ,vol. 9, pp. 1692- 1703 ,(1991) , 10.1200/JCO.1991.9.9.1692
W.W. ten Bokkel Huinink, A.M. Prove, M. Piccart, W. Steward, T. Tursz, J. Wanders, H. Franklin, M. Clavel, J. Verweij, M. Alakl, M. Bayssas, S.B. Kaye, A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group. Annals of Oncology. ,vol. 5, pp. 527- 532 ,(1994) , 10.1093/OXFORDJOURNALS.ANNONC.A058907
E A Eisenhauer, W W ten Bokkel Huinink, K D Swenerton, L Gianni, J Myles, M E van der Burg, I Kerr, J B Vermorken, K Buser, N Colombo, European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. Journal of Clinical Oncology. ,vol. 12, pp. 2654- 2666 ,(1994) , 10.1200/JCO.1994.12.12.2654
Françoise Guéritte-Voegelein, François Lavelle, Daniel Guénard, Marie-Christine Bissery, Experimental Antitumor Activity of Taxotere (RP 56976, NSC 628503), a Taxol Analogue Cancer Research. ,vol. 51, pp. 4845- 4852 ,(1991)
B Chevallier, P Fumoleau, P Kerbrat, V Dieras, H Roche, I Krakowski, N Azli, M Bayssas, M A Lentz, M Van Glabbeke, Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer. Journal of Clinical Oncology. ,vol. 13, pp. 314- 322 ,(1995) , 10.1200/JCO.1995.13.2.314
P. H. Konits, J. Aisner, D. A. Van Echo, K. Lichtenfeld, P. H. Wiernik, Mitomycin C and vinblastine chemotherapy for advanced breast cancer Cancer. ,vol. 48, pp. 1295- 1298 ,(1981) , 10.1002/1097-0142(19810915)48:6<1295::AID-CNCR2820480607>3.0.CO;2-H
Jean Noel. Denis, Andrew E. Greene, Daniel. Guenard, Francoise. Gueritte-Voegelein, Lydie. Mangatal, Pierre. Potier, Highly efficient, practical approach to natural taxol Journal of the American Chemical Society. ,vol. 110, pp. 5917- 5919 ,(1988) , 10.1021/JA00225A063
C Kamby, B Bruun Rasmussen, B Kristensen, Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence. British Journal of Cancer. ,vol. 60, pp. 252- 257 ,(1989) , 10.1038/BJC.1989.264